Friday, July 10, 2026

Drug profile · INN

clopidogrel

clopidogrel (BLOOMS CLOPIDOGREL) is a purinergic receptor p2y12 antagonist. Associated with Alphapharm Pty Ltd.

EMA: approved TGA: approved NMPA: clinical trials Blood and blood forming organs (B01) B01AC04
Patents linked 9
Pipeline programs 31
News articles 1
Drug details — clopidogrel

Quick answer

clopidogrel (BLOOMS CLOPIDOGREL) is a purinergic receptor p2y12 antagonist. Associated with Alphapharm Pty Ltd.

Key facts

INN clopidogrel
Brand BLOOMS CLOPIDOGREL
Mechanism Purinergic receptor P2Y12 antagonist
Therapeutic class Blood and blood forming organs (B01)
ATC code B01AC04

Mechanism of action

Purinergic receptor P2Y12 antagonist

Approval history

Authority Status Date
EMA approved
TGA approved
NMPA clinical trials

Recent coverage

Pipeline programs

  1. CAMER5UA Phase 3 · United Therapeutics Europe · Cervical Artery Dissection
  2. Clopidogrel Phase 3 · Eli Lilly and · Acute Coronary Syndrome
  3. Etude DAPT-CTO Phase 3 · Ishita Pharma - · chronically occluded coronary artery
  4. Secukinumab (75 mg) Phase 3 · Novartis India · Psoriatic Arthritis
  5. Wegovy solution for Diabetes Mellitus, Cardiovascul… Phase 3 · Istituto Gentili Italia · Diabetes Mellitus, Cardiovascular disease, Overweight (BMI ≥
  6. clopidogrel and aspirin Phase 3 · Chinese Academy of · Atherosclerosis
  7. Dopacis 90 MBq/ml oplossing voor injectie Phase 2 · CERo Therapeutics · patients with newly discovered brain metastases (non-small c
  8. acetylsalicylic acid Phase 2 · Protalix Biotherapeutics · Upper Gastrointestinal Mucosal Damage

Related & competitor drugs

  1. apixaban Blood and blood forming organs (B01)
  2. berotralstat Blood and blood forming organs (B06)
  3. bivalirudin Blood and blood forming organs (B01)
  4. c1 inhibitor (human) Blood and blood forming organs (B06)
  5. dabigatran etexilate Blood and blood forming organs (B01)
  6. eltrombopag Blood and blood forming organs (B02)
  1. US 10280197

    Discovery of the first selective C5A receptor 2 (C5L2/C5AR2) ligands

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 8663602

    Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 8501678

    Variant activin receptor polypeptides and uses thereof

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 8410043

    Stabilized activin IIB receptor polypeptides and uses thereof

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 8187874

    Drug discovery method

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7928138

    Marine actinomycete taxon for drug and fermentation product discovery

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7879576

    Marine actinomycete taxon for drug and fermentation product discovery

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7144723

    Marine actinomycete taxon for drug and fermentation product discovery

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 6858402

    System for discovering and producing polypeptides that cause TNF receptor shedding

    Expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is clopidogrel?

clopidogrel (BLOOMS CLOPIDOGREL) is a purinergic receptor p2y12 antagonist. Associated with Alphapharm Pty Ltd.

What is the brand name for clopidogrel?

BLOOMS CLOPIDOGREL is a marketed brand name for clopidogrel. Check FDA Drugs@FDA for the current US label holder and prescribing information.